Bromocriptine

Back to search

Molecule Structure

Scientific Name

Bromocriptine

Description of the Drug

Bromocriptine is a dopamine D2 receptor agonist used for the treatment of galactorrhea due to hyperprolactinemia and other prolactin-related conditions, as well as in early Parkinsonian Syndrome.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01200

Brand Name(s)

Parlodel

Company Owner(s)

Padagis Us Llc, Veroscience Llc, Sandoz Inc, Validus Pharmaceuticals Llc, Lek Pharmaceutical And Chemical Co Dd, Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
D2-like dopamine receptor PROTEIN FAMILY AGONIST CHEMBL2331075

Unichem Links

SureChEMBL SCHEMBL25297
PharmGKB PA448671
Human Metabolome Database HMDB0015331
DrugBank DB01200
PubChem: Thomson Pharma 14765834 14765835
PubChem 31101
NMRShiftDB 60027642
LINCS LSM-6550
Nikkaji J16.988I
PDBe 08Y
BindingDB 81993
EPA CompTox Dashboard DTXSID1022687
DrugCentral 403
Metabolights MTBLC3181
Brenda 147619 147312
ChemicalBook CB6136426
Guide to Pharmacology 35
rxnorm CYCLOSET BROMOCRIPTINE BROMOCRIPTINE MESYLATE PARLODEL
KEGG Ligand C06856
ChEBI 3181
ZINC ZINC000053683151